Emily, a long-time customer from Australia who has been working with the BLOOM tech team for two years, recently purchased our best-selling products, including Retatrutide 30mg, 15mg and Tirzepatide 60mg. After the sales team provided a quote, the client successfully made payment via wire transfer. Upon receiving the payment, we immediately shipped the order. Using Australia Post's dedicated customs clearance service, the shipment cleared customs smoothly within five days. After arriving at the destination, the goods were transferred to a local carrier and successfully delivered. The client expressed great satisfaction with our product quality and service and indicated a willingness to seek out more local clients for transactions to further expand our collaboration.
 |
 |
 |
 |
 |
 |
I. Client Background and Partnership History
Powerful Solutions For Business Growth
Emily, a client based in Melbourne, Australia, works in the health management industry and has established a network of clients in the local market. Two years ago, Emily first came into contact with the BLOOM Tech team through Google Ads. At the time, she was seeking high-quality, cost-effective peptide raw materials and finished product solutions for her local clients.
Following initial validation through small-batch trial orders, Emily highly praised BLOOM Tech's product purity, stability, and supply responsiveness, leading to the establishment of a stable partnership that has lasted for two years.
Over the past two years, Emily has purchased a variety of peptide products from BLOOM Tech, including but not limited to GLP-1 peptides, NAD+, and other functional peptides, with the cumulative order value steadily increasing. This collaborative path-from small orders to large orders, and from trial orders to regular orders-is a typical model of how BLOOM Tech cultivates relationships with clients in overseas markets.
Customer Feedback and Intentions for Expanding Partnerships
Emily inspected the goods immediately upon receipt and expressed satisfaction with the product's appearance, purity labeling, and packaging integrity. In her feedback, she specifically noted:
"I've been working with BLOOM Tech for two years now, and the quality has been consistently excellent every time. The shipping speed this time also exceeded my expectations-customs clearance was completed in just five days, which is rare in Australia. My end customers are very impressed with the product's performance, and I hope to recommend you to more local partners in Australia."
Based on this positive experience, Emily has clearly expressed her willingness to serve as BLOOM Tech's local promotion hub in the Australian market. She plans to leverage her own customer network to introduce more local end customers to BLOOM Tech, thereby upgrading the relationship from a "single client" to a "channel partner."
Analysis of Actual Product Applications
Clinical Data Support:
SURMOUNT-1 Trial: In this 72-week Phase III clinical trial, participants in the tirzepatide 15 mg group achieved an average weight loss of 22.5%, representing nearly a quarter of their body weight-far exceeding the results of existing single-target GLP-1 drugs.
SURPASS Series Trials: In the management of type 2 diabetes, the Tirzepatide 15 mg group achieved HbA1c reductions of 2.3%–2.58%, accompanied by significant weight loss, delivering dual benefits of "blood sugar control and weight loss."
Clinical Data Support:
Phase II Clinical Trial (Results Published in 2024): The Retatrutide 12 mg group achieved an average weight loss of 24.2% over 48 weeks, with some high-dose groups (such as 12 mg or higher) achieving weight loss close to 26%.
These results position Retatrutide as one of the most potent weight-loss drugs currently in development based on publicly available data, and it is viewed by the industry as a strong contender for the title of "next-generation weight-loss drug leader."
Real-world application case:
Emily herself is an early adopter of Retatrutide. When she first started using the product two years ago, she weighed 82 kg. After consistently following a 30 mg + 15 mg cyclical regimen, her weight has now stabilized at around 66 kg, and her body fat percentage has decreased by 8 percentage points.
She shares her usage data and body composition reports with local clients, serving as the most persuasive "living advertisement."
Real-world application case:
On Emily's recommendation, one of her clients-a fitness trainer-also began using the Retatrutide regimen. This client, who originally weighed 95 kg, dropped to 87 kg after 12 weeks of use. Notably, he experienced no significant muscle loss while maintaining a high-intensity training regimen, demonstrating the "fat loss with muscle preservation"advantage offered by the glucagon target.
Key Insight:
BLOOM Tech's competitiveness in overseas markets stems not only from the quality of its products but also from its end-to-end service capabilities-from prompt quotation responses and convenient payment options to efficient logistics and after-sales follow-up. The reliability of every step in this process helps build trust, which serves as a foundation for long-term partnerships. Emily's transformation from a "buyer" to a "referrer" is a prime example of how this trust translates into tangible results.
